The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An antibody derived from a cured AML patient to identify a unique epitope on CD43 (CD43s) as a novel target for acute myeloid leukemia and myelodysplastic syndrome.
 
Mette D. Hazenberg
Employment - AIMM Therapeutics (I)
Stock and Other Ownership Interests - AIMM Therapeutics (I)
Research Funding - AIMM Therapeutics (I)
Patents, Royalties, Other Intellectual Property - AIMM Therapeutics (I)
 
Marijn Gillissen
Employment - AIMM Therapeutics
Research Funding - AIMM Therapeutics
 
Greta De Jong
No Relationships to Disclose
 
Etsuko Yasuda
Employment - AIMM Therapeutics
Stock and Other Ownership Interests - AIMM Therapeutics
 
Sophie Levie
Employment - AIMM Therapeutics
 
Koen Wagner
Employment - AIMM Therapeutics
 
Arjen Bakker
Employment - AIMM Therapeutics
Stock and Other Ownership Interests - AIMM Therapeutics
 
Martijn Kedde
Employment - AIMM Therapeutics
 
Paul Hensbergen
No Relationships to Disclose
 
Julien Villaudy
Employment - AIMM Therapeutics
 
Pauline Van Helden
Employment - AIMM Therapeutics
 
Hergen Spits
Employment - AIMM Therapeutics
Stock and Other Ownership Interests - AIMM Therapeutics
Patents, Royalties, Other Intellectual Property - AIMM Theraptics